MEDIZEN HUMANCARE Inc.

A236340

KR7236340006

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-23 pm EDT			5-day change	1st Jan Change
5,190 ^KRW	+1.76%		+4.01%	+29.75%

2023	MEDIZEN HUMANCARE Inc. announced that it has received KRW 1.96 billion in funding from Daesang Well Life Co., Ltd.	CI
2023	MEDIZEN HUMANCARE Inc. announced that it expects to receive KRW 1.96 billion in funding from Daesang Well Life Co., Ltd.	CI

PT Indo Medizen Sehat announced that it has received KRW 112.875 million in funding from MEDIZEN HUMANCARE Inc.

August 25, 2022

On August 26, 2022, PT Indo Medizen Sehat closed the transaction.

Latest news about MEDIZEN HUMANCARE Inc.

MEDIZEN HUMANCARE Inc. announced that it has received KRW 1.96 billion in funding from Daesang Well Life Co., Ltd.	23-01-29	CI
MEDIZEN HUMANCARE Inc. announced that it expects to receive KRW 1.96 billion in funding from Daesang Well Life Co., Ltd.	23-01-19	CI
PT Indo Medizen Sehat announced that it has received KRW 112.875 million in funding from MEDIZEN HUMANCARE Inc.	22-08-25	CI
PT Indo Medizen Sehat announced that it expects to receive KRW 112.875 million in funding from MEDIZEN HUMANCARE Inc.	22-08-24	CI
MEDIZEN HUMANCARE Inc. announced that it expects to receive KRW 3.469998 billion in funding	22-02-10	CI
MEDIZEN HUMANCARE Inc. announced that it has received KRW 999.992 million in funding	21-12-19	CI
MEDIZEN HUMANCARE Inc. announced that it has received KRW 1.499988 billion in funding	21-12-14	CI
MEDIZEN HUMANCARE Inc. announced that it expects to receive KRW 999.992 million in funding	21-12-09	CI
MEDIZEN HUMANCARE Inc. announced that it expects to receive KRW 1.499988 billion in funding	21-12-06	CI
HPio Co., Ltd. and BM International Holdings Co., Ltd. acquired 7.4% stake in MEDIZEN HUMANCARE Inc. for KRW 1.4 billion.	20-11-08	CI
Medizen Humancare Inc Co., Ltd announced that it has received KRW 1.999982 billion in funding from Woori Bank Co., Ltd., Investment Arm, Industrial Bank of Korea, Investment Arm	18-10-23	CI
Medizen Humancare Inc Co., Ltd announced that it expects to receive KRW 1.999982 billion in funding from Woori Bank Co., Ltd., Investment Arm, Industrial Bank of Korea, Investment Arm	18-10-15	CI
Medizen Humancare Co.,Ltd. announced that it has received KRW 1 billion in funding	17-02-16	CI
Medizen Humancare Co.,Ltd. announced that it expects to receive KRW 1 billion in funding	17-02-15	CI
Kiwoom Growth 15th Secondary Investment Fund managed by Kiwoom Investment Co., Ltd. acquired 1.96% stake in Medizen Humancare Co.,Ltd. for KRW 650 million.	17-01-23	CI
An individual and a company acquired 2.5% stake in Medizen Humancare Co.,Ltd. from K2 Liquidity Solution Fund managed by K2 Investment Partners LLC.	17-01-18	CI
Medizen Humancare Co.,Ltd. announced that it has received KRW 2.5 billion in funding	17-01-15	CI
Medizen Humancare Co.,Ltd. announced that it expects to receive KRW 2.5 billion in funding	17-01-12	CI
Samsung Pharmaceutical Co., Ltd. completed the sale of 17.13% stake in Medizen Humancare Co.,Ltd.	15-10-04	CI
Samsung Pharmaceutical Co., Ltd. agreed to sell 17.13% stake in Medizen Humancare Co.,Ltd. for KRW 2 billion.	15-08-31	CI

Medizen Humancare Inc Co., Ltd is a Korea-based company mainly engaged in the provision of disease prediction services. The Company is involved in the provision of disease prediction services named My-Genome Check (M-CHECK). In addition, it is involved in the conduction of research projects, as well as the manufacturing and sale of saliva kits.

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
MEDIZEN HUMANCARE INC.	+29.75%	8.76M
EXACT SCIENCES CORPORATION	-32.63%	9.2B
IOVANCE BIOTHERAPEUTICS, INC.	+23.12%	2.8B
BGI GENOMICS CO., LTD.	-18.33%	2.05B
VERACYTE, INC.	-24.39%	1.59B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+65.65%	1.44B
CAREDX, INC	+32.83%	830M
SEEGENE, INC.	-6.77%	720M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-29.80%	507M
CURIOX BIOSYSTEMS CO., LTD	+0.40%	297M

Bio Diagnostics & Testing

MEDIZEN HUMANCARE Inc.

Equities

A236340

KR7236340006

Biotechnology & Medical Research

PT Indo Medizen Sehat announced that it has received KRW 112.875 million in funding from MEDIZEN HUMANCARE Inc.

Latest news about MEDIZEN HUMANCARE Inc.

Chart MEDIZEN HUMANCARE Inc.

Company Profile

Sector Bio Diagnostics & Testing